As we have informed here, US private equity investor Battery Ventures has acquired Swiss-based SaaS startup Avrios International. Avrios offers a cloud-based fleet management platform, used by more than a thousand customers with around 120,000 vehicles.
Tags :Gian Geel
VISCHER has advised ADVANZ PHARMA, a specialty pharmaceutical company headquartered in London, on all Swiss legal aspects of its USD 450m acquisition of the ex-US business of Intercept Pharmaceuticals, spanning from due diligence to transactional
A group of investors advised by Rigeto Unternehmerkapital (“Rigeto”) has acquired 100% of the shares in Laser Beauté Med, headquartered in Sion with additional locations in Monthey and Visp. The oldest dermatology clinic in the Swiss
Mainova, an energy supplier based in Frankfurt am Main, has acquired a majority stake in the Bavarian energy service provider mobiheat, including its subsidiaries in Austria and Switzerland, from Energieversorgung Offenbach (EVO) and the mobiheat
Nautilus, an innovation specialist in home fitness, has entered into a definitive agreement to acquire Zurich based Vay, a company specialising in computer vision and AI technology solutions and the provider of motion detection and
Vischer acted as legal counsel for Haya Therapeutics, a company developing precision medicines that target tissue and cell-specific long non-coding RNAs (lncRNAs), on the closing of its CHF 18 million seed round. The financing was led
VISCHER advises T3 Pharmaceuticals on all legal issues in connection with the transaction. The team consists of Christian Wyss (Partner, Corporate / M&A - pictured), Pauline Pfirter (Associate, Corporate / M&A), Ruben Masar (Associate, Corporate /
The team included partner Christian Wyss (Life Sciences - pictured), associate Timothy Woodtli (Corporate/M&A), associate Francesca Pesenti (Corporate/M&A), and associate Gian Geel (Employment).
FoRx Therapeutics, a Basel-based biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress (DRS) pathways activated in cancer, completes a EUR 10M seed-financing round
Mitsubishi Chemical Advanced Materials (MCAM), a leading global manufacturer of high performance materials, had announced in February to have entered into an agreement for the acquisition of all the recycling activities of Minger Kunststofftechnik through